Skip to content
The Pure Journal Ingredient Spotlight

Ingredient Spotlight

Vitamin D3 + K2: Why You Should Never Take One Without the Other

High-dose D3 without K2 can calcify the wrong tissues. The pairing isn't a marketing trick — it's a clinical necessity.

Dr. Devin RyersonFounder, Pure Prescriptions
August 2026 5 min read

Half the country is taking Vitamin D3. Fewer than one in ten are pairing it with K2. That’s a problem — and it’s one the supplement industry has largely failed to communicate.

I want to be direct about this: taking high-dose Vitamin D3 without adequate K2 isn’t just a missed opportunity. It’s a physiological mismatch that can direct calcium into the wrong tissues. The cardiovascular and bone implications of getting this wrong are not trivial. And yet most Vitamin D3 products on the market are sold as standalone supplements, often at doses high enough to matter, with no K2 in sight.

Let me explain the mechanism — and then explain why we solved this problem inside our Premium Omega-3 Plus formula, where both nutrients belong.

The Vitamin D3 Story: What It Actually Does

Vitamin D3 — cholecalciferol — is a fat-soluble hormone your skin synthesizes from UVB radiation. When UVB hits skin tissue, 7-dehydrocholesterol is converted to previtamin D3, which then converts to D3 and is carried via the bloodstream to the liver and kidneys for activation. The active form, calcitriol, is what does the physiological work.

The functions are extensive. Vitamin D3 regulates immune function, supports bone density by enhancing intestinal calcium absorption, plays a role in muscle performance, and is involved in over 200 gene expressions. The receptor for vitamin D — the VDR — is found in virtually every tissue type in the body. This is not a niche nutrient. It’s foundational.

The deficiency problem is real and widespread. The average American gets insufficient UVB exposure for about six months of the year depending on latitude. People who work indoors, wear sunscreen consistently, or live north of the 35th parallel are particularly at risk. Current estimates suggest that between 40% and 70% of Americans are vitamin D insufficient — and many who test within the ‘normal’ range are at the lower end of a range that wasn’t designed to represent optimal function.5

“Vitamin D3 opens the gate for calcium absorption. K2 tells that calcium exactly where to go. Without both, the gate is open but the signaling is wrong.”

The K2 Story: The Calcium Traffic Controller

Here’s where most people — and most supplement companies — get it wrong.

When you take Vitamin D3, it increases intestinal absorption of calcium. That’s by design. The goal is to deliver more calcium to bones, improving density and reducing fracture risk. But calcium is a systemic mineral — it circulates throughout the body. If there isn’t an adequate signaling system directing calcium to bone and away from soft tissue, that absorbed calcium can end up deposited in arterial walls, joints, and other places where it causes harm.

Vitamin K2 is that signaling system.

K2 activates two critical proteins: osteocalcin, which binds calcium in bone matrix, and Matrix Gla Protein (MGP), which actively inhibits calcium from depositing in arterial walls and soft tissue. Without sufficient K2, both of these proteins remain in their inactive (carboxylated) forms — meaning osteocalcin can’t anchor calcium to bone, and MGP can’t prevent it from ending up in your arteries.*

Osteocalcin

A bone matrix protein that, when K2-activated, physically binds calcium and integrates it into bone crystal structure.

Studies show that undercarboxylated osteocalcin — the inactive form that accumulates without sufficient K2 — is strongly associated with reduced bone mineral density and increased fracture risk.

Matrix Gla Protein (MGP)

The most potent known inhibitor of arterial calcification.

Requires K2 for activation. When K2 is insufficient, MGP remains inactive and cannot perform its protective function. High levels of undercarboxylated MGP are an independent predictor of cardiovascular events in clinical studies — a finding that has been replicated across multiple research groups.

MK-7 vs MK-4

Not all K2 is equal.

Menaquinone-7 (MK-7) has a half-life of approximately 72 hours versus MK-4’s 1–2 hours, meaning a once-daily dose of MK-7 maintains stable blood levels throughout the day. MK-7 is also more bioavailable and has been used in virtually every rigorous clinical study demonstrating K2’s cardiovascular and bone effects. We use MK-7.

The Clinical Evidence for the Pairing

The synergy between D3 and K2 has been documented in multiple clinical contexts. A three-year trial published in Osteoporosis International found that women supplementing with both D3 and K2 (MK-7) showed significantly greater improvements in bone mineral density than those taking D3 alone. The K2-alone and placebo groups showed the least improvement.

On the cardiovascular side, the Rotterdam Study — a large prospective cohort study — found that high dietary intake of K2 (but not K1) was significantly associated with reduced coronary calcification, reduced cardiovascular mortality, and reduced all-cause mortality. The protection appeared strongest for MK-7 and longer-chain menaquinones.12

More recently, a 2015 three-year study in Thrombosis and Haemostasis randomized postmenopausal women to MK-7 or placebo. The K2 group showed significantly less stiffening of the arterial walls compared to placebo — a direct measure of the anti-calcification effect that MGP activation provides.4

“The Rotterdam Study didn’t show that K2 was ‘nice to have.’ It showed that high K2 intake was associated with 57% lower risk of dying from heart disease. That’s not a detail. That’s the entire story.”

Why Omega-3 Is the Perfect Delivery Vehicle

Both Vitamin D3 and Vitamin K2 are fat-soluble. This is not a minor detail — it’s the core of why their delivery format matters.

Fat-soluble nutrients require dietary fat to absorb properly. Without it, they pass through the gastrointestinal tract largely intact, without making it into systemic circulation. Most D3 capsules on the market are gelatin-based and contain no fat matrix — meaning if you take them on an empty stomach or with a low-fat meal, you’re absorbing a fraction of what the label says.

This is why including D3 and K2 inside Premium Omega-3 Plus is a genuine formulation decision, not just a bundling convenience. The fish oil itself — a concentrated source of dietary fat — provides the lipid matrix that D3 and K2 need to absorb efficiently. You’re delivering all three fat-soluble nutrients together, in the same capsule, with the fat carrier they require. That’s not an add-on. That’s intelligent formulation.

We add VESIsorb® technology to further enhance absorption — a self-emulsifying colloidal delivery system that creates a micronized dispersion of the oil-soluble nutrients in the gut, increasing the surface area available for absorption even in the absence of a large dietary fat load. The result is substantially better bioavailability than a standard fish oil softgel, regardless of what you ate for lunch.

What’s Actually in Premium Omega-3 Plus

The formula delivers: 480mg DHA, 190mg EPA (both from molecularly distilled fish oil), 1000 IU Vitamin D3 (cholecalciferol), and 45mcg Vitamin K2 (as MK-7, menaquinone-7). Delivered in a single softgel via VESIsorb® technology for enhanced bioavailability.

The fish oil is molecularly distilled — a purification process that removes heavy metals, dioxins, and PCBs while preserving the EPA and DHA content intact. We add natural Vitamin E (as mixed tocopherols) as a preservative, which prevents oxidation — a significant problem with cheap fish oil products that nobody talks about. Rancid fish oil smells bad, tastes worse, and generates lipid peroxides that can increase, rather than reduce, oxidative stress. Premium Omega-3 Plus doesn’t smell fishy because it isn’t rancid.

How to Take It — and When

Two softgels of Premium Omega-3 Plus with your largest meal of the day. That’s it. The VESIsorb® technology improves absorption even without a high-fat meal, but I prefer to take it with food out of habit — typically my midday meal, when I have the most dietary fat available from a mixed diet.

Because D3 and K2 are both fat-soluble, their absorption from fish oil is continuous rather than acute — blood levels build over days and weeks of consistent daily intake. Like all fat-soluble nutrients, the goal isn’t a single-day spike. It’s maintaining a steady physiological baseline through daily, consistent use.

If you’re currently taking a standalone D3 supplement without K2, this is the moment to reconsider that decision. Not because the D3 is doing nothing — it likely is doing something useful. But because without K2, the calcium mobilization that D3 drives isn’t being properly directed. The VDR is open. The calcium is moving. The question is: where is it going?

With K2, you know the answer. Into bone. Away from arteries. Exactly where it belongs.

References

  1. 1.Geleijnse JM et al. “Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study.” Journal of Nutrition, 2004.
  2. 2.Beulens JWJ et al. “High dietary menaquinone intake is associated with reduced coronary calcification.” Atherosclerosis, 2009.
  3. 3.Gast GCM et al. “A high menaquinone intake reduces the incidence of coronary heart disease.” Nutrition, Metabolism and Cardiovascular Diseases, 2009.
  4. 4.Knapen MHJ et al. “Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: double-blind randomised clinical trial.” Thrombosis and Haemostasis, 2015.
  5. 5.National Institutes of Health — Office of Dietary Supplements: Vitamin D Fact Sheet for Health Professionals.

The Pure Journal

Continue Reading

$25 Pure Prescriptions Store Credit

Member Reward

A gift for
joining us.

Join our community and receive $25 in store credit on orders over $99 for Pure Prescriptions and NewGreens products.

    No spam. Unsubscribe at any time.